GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 793 filers reported holding GLAXOSMITHKLINE PLC in Q2 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,710,000 | -4.0% | 44,750 | 0.0% | 0.06% | -4.5% |
| Q2 2021 | $1,782,000 | +11.6% | 44,750 | 0.0% | 0.07% | +3.1% |
| Q1 2021 | $1,597,000 | -3.0% | 44,750 | 0.0% | 0.06% | -7.1% |
| Q4 2020 | $1,647,000 | -2.2% | 44,750 | 0.0% | 0.07% | -13.6% |
| Q3 2020 | $1,684,000 | -7.7% | 44,750 | 0.0% | 0.08% | -13.8% |
| Q2 2020 | $1,825,000 | +46.2% | 44,750 | +35.8% | 0.09% | +17.5% |
| Q1 2020 | $1,248,000 | -19.4% | 32,950 | 0.0% | 0.08% | 0.0% |
| Q4 2019 | $1,548,000 | +10.1% | 32,950 | 0.0% | 0.08% | +6.7% |
| Q3 2019 | $1,406,000 | +6.6% | 32,950 | 0.0% | 0.08% | +7.1% |
| Q2 2019 | $1,319,000 | -4.2% | 32,950 | 0.0% | 0.07% | -2.8% |
| Q1 2019 | $1,377,000 | +9.4% | 32,950 | 0.0% | 0.07% | -2.7% |
| Q4 2018 | $1,259,000 | -4.9% | 32,950 | 0.0% | 0.07% | +13.8% |
| Q3 2018 | $1,324,000 | -0.3% | 32,950 | 0.0% | 0.06% | -1.5% |
| Q2 2018 | $1,328,000 | +3.2% | 32,950 | 0.0% | 0.07% | +1.5% |
| Q1 2018 | $1,287,000 | +10.1% | 32,950 | 0.0% | 0.06% | +10.2% |
| Q4 2017 | $1,169,000 | -12.6% | 32,950 | 0.0% | 0.06% | -16.9% |
| Q3 2017 | $1,338,000 | -5.8% | 32,950 | 0.0% | 0.07% | -9.0% |
| Q2 2017 | $1,421,000 | +2.3% | 32,950 | 0.0% | 0.08% | +1.3% |
| Q1 2017 | $1,389,000 | +9.5% | 32,950 | 0.0% | 0.08% | +4.1% |
| Q4 2016 | $1,269,000 | -10.7% | 32,950 | 0.0% | 0.07% | -9.8% |
| Q3 2016 | $1,421,000 | -0.5% | 32,950 | 0.0% | 0.08% | -2.4% |
| Q2 2016 | $1,428,000 | +6.9% | 32,950 | 0.0% | 0.08% | +6.3% |
| Q1 2016 | $1,336,000 | +0.5% | 32,950 | 0.0% | 0.08% | 0.0% |
| Q4 2015 | $1,330,000 | +5.0% | 32,950 | 0.0% | 0.08% | -2.5% |
| Q3 2015 | $1,267,000 | -7.7% | 32,950 | 0.0% | 0.08% | 0.0% |
| Q2 2015 | $1,372,000 | -9.8% | 32,950 | 0.0% | 0.08% | -10.0% |
| Q1 2015 | $1,521,000 | +8.0% | 32,950 | 0.0% | 0.09% | +7.1% |
| Q4 2014 | $1,408,000 | -16.1% | 32,950 | -9.7% | 0.08% | -17.6% |
| Q3 2014 | $1,678,000 | -14.0% | 36,500 | 0.0% | 0.10% | -13.6% |
| Q2 2014 | $1,952,000 | +0.1% | 36,500 | 0.0% | 0.12% | -5.6% |
| Q1 2014 | $1,950,000 | +0.1% | 36,500 | 0.0% | 0.12% | -0.8% |
| Q4 2013 | $1,949,000 | +6.4% | 36,500 | 0.0% | 0.13% | -3.8% |
| Q3 2013 | $1,831,000 | +0.4% | 36,500 | 0.0% | 0.13% | -3.7% |
| Q2 2013 | $1,824,000 | – | 36,500 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |